Letter From the Editor: Building a Better FDA

  This March, the physician Scott Gottlieb resigned from his post as commissioner of the FDA to spend more time with his family. Dr Gottlieb’s appointment, […]

Letter From the Editor: Talk to Me

Medical communication is increasingly nonverbal. Electronic medical records, e-mail, texting, websites, search engines, and even social media all make us depend less than ever on the […]

Letter From the Editor: Clinical Advances: Past and Present

  This issue kicks off the 17th year of publication of Clinical Advances in Hematology & Oncology, with more than 2000 articles now listed in PubMed. […]

Letter From the Editor: With a Little Help From My Friends

My two-year tenure as Editor-in-Chief ends with this issue. I was struggling a bit with a topic for this month’s letter, until I read an article […]

Letter From the Editor: On RELEVANCE

Many effective treatment options exist for follicular lymphoma. Patients with low tumor burden can be managed initially with deferral of therapy (watch and wait). Patients with […]

The Fast-Changing World of CLL

  Do you remember when CLL was managed largely with chlorambucil? The big decision was whether to give the agent daily or in pulses every two […]

Letter From the Editor: More CRO Fun

Last year, coming off the heels of an editorial by Mikkael Sekeres in ASH Clinical News, I wrote a piece for this column called “Take Back […]

Letter From the Editor: Mentoring

I have just returned from Scottsdale, Arizona, where I spent a day at the Lymphoma Research Foundation Clinical Research Mentoring Program (LCRMP). This four-day workshop is designed […]

Letter From the Editor: Trivia Night

Last night, my wife and I went to a fund-raiser for our local elementary school. The school, called North Glendale, is everything a public school should […]

Letter From the Editor: Another Plenary, More Uncertainty

  I write this letter 5 days after the 2017 ASH annual meeting. The ASH meeting is always a highlight of the year for hematologists. It is […]

Letter From the Editor: Protests

I have been thinking about protests lately—largely in response to the NFL national anthem controversy, which has left me wondering about the most effective way to protest. […]

Letter From the Editor: In Memory of Oliver Press, MD, PhD

We have lost a giant. For those of us who knew and worked with Oliver Press, it feels like a punch in the gut. Some individuals […]

Letter from the Editor: How to Treat Hodgkin Lymphoma

  Last weekend, I attended the 2017 ASH Meeting on Hematologic Malignancies. This is an incredible 2-day meeting organized around a series of “How I Treat” […]

Letter From the Editor: Book Club: The Panama Canal

I don’t know how people in our profession find time to read for pleasure. A stack of medical material is always awaiting my attention. Until earlier this […]

Letter From the Editor: Take Back the Research

If you do not read the Editor’s Corner by Mikkael Sekeres in ASH Clinical News, you should. It is a good read. Mikkael’s piece in the […]

ASCO Cage Match: BR vs R-CHOP

I recently attended the ASCO annual meeting in Chicago. It’s huge, but remarkably organized and well run. I think it helps that the meeting has been held […]

Letter From the Editor: In Memory of Robert L. Comis, MD

I recently attended the Spring ECOG-ACRIN Cancer Research Group meeting. One evening I was able to spend some time at the bar with Group co-chair Bob Comis, […]

Letter From the Editor: Buyer Beware!

I’m writing this column in part as a public service for any young faculty members who might be getting close to purchasing their first home, as […]

Letter from the Editor: Affordable Care?

Nobody knew health care could be so complicated. – President Donald Trump Actually, lots of people did. In the president’s defense, I am sure he never […]

Letter From the Editor: When Will We Beat R-CHOP?

I was joking around with one of my AML colleagues a while back, teasing him about giving 7 + 3 chemotherapy. That recipe has been around […]